To further validate the correlation of Rac1 expression with breast cancer chemoresistance, we collected 133 core needle biopsies from breast cancer patients before neoadjuvant chemotherapy, which were then treated with platinum-based drugs, Taxanes, and Doxorubicin. This evidence concerns the gene RAC1 and breast carcinoma.